IRVINE, CA / ACCESSWIRE / March 17, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Natus Medical Incorporated (“Natus” or the “Company”) (NASDAQ: BABY). Investors, who purchased or otherwise acquired Natus shares between October 16, 2015 and April 3, 2016, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 31, 2017 lead plaintiff motion deadline.

If you purchased shares of Natus during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The Complaint states that throughout the Class Period, Natus issued materially false and/or misleading statements, as well as failed to disclose material adverse facts about its business, operations, and prospects, including that: the government of Venezuela could not render tens of millions of dollars in prepayments to Natus, required in October 2015; that Natus did not hold the means to effectively enforce its rights under its supply contract; Natus’ revenues related to the supply contract were dependent on the outcome of Venezuelan elections; and therefore, Natus could not effectively achieve the increased guidance offered by Defendants, which lacked a reasonable basis. When this information was disclosed to the public, the value of Natus Medical Incorporated fell, causing investors harm.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 457570

LOS ANGELES, CA / ACCESSWIRE / March 17, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against ReWalk Robotics Ltd (“Rewalk” or the “Company”) (NASDAQ: RWLK). Investors, who purchased or otherwise acquired Rewalk shares pursuant and/or traceable to the Company’s Stock Offering on or about September 12, 2014, are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The Complaint alleges that during the Class Period, the Registration Statement and Prospectus issued regarding the Initial Public Offering did not disclose material information, including that ReWalk did not comply with “special controls” requirements.

When this information was revealed to the investing public, the value of Rewalk fell, causing harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 457572

LOS ANGELES, CA / ACCESSWIRE / March 17, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Roadrunner Transportation Systems Inc. (“Roadrunner” or the “Company”) (NYSE: RRTS). Investors, who purchased or otherwise acquired Roadrunner shares between May 8, 2014 and January 30, 2017, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 03, 2017 lead plaintiff deadline.

To participate in this class action lawsuit, click here, or call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

Roadrunner disclosed on January 30, 2017 that its financial statements would need to be edited. The Company attributes the problem to accounting mistakes that Roadrunner anticipates will necessitate changes of $20 million to $25 million. When this information was released to the public, the value of Roadrunner dropped, causing shareholders harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 457568

NEW YORK, NY / ACCESSWIRE / March 17, 2017 / BioHiTech Global (OTCQB: BHTG) CEO, Frank E. Celli, will be a featured presenter at the MicroCap Conference on April 4th in New York City, sponsored by The Special Equities Group and Maxim Group. Management will be available for one-on-one investor meetings throughout the conference.

CONFERENCE OVERVIEW AND STRUCTURE

The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other investors.

The MicroCap Conference will take place in New York City at the Essex House on April 4th. Registration will begin on Tuesday, April 4th, at 7:00AM, and the event ends with a reception in the evening. The day will be jam-packed with company presentations, one-on-one meetings, good food, and plenty of time to network with other investors over drinks at the reception. This event does not allow service providers – only portfolio managers, analysts, and private investors.

REGISTRATION FOR INVESTORS

To register, please go to our website (www.microcapconf.com) and click “Register.”

PARTICIPATING COMPANIES

For our most updated list of companies, please go to our website (http://microcapconf.com/conferences/new-york-2017/).

MARQUEE SPONSORS

The Special Equities GroupMaxim Group

PARTICIPATING SPONSORS

MZ GroupCore IRMarcumPCG Advisory Group

News Compliments of ACCESSWIRE.

About BioHiTech Global

BioHiTech Global (OTCQB: BHTG) (the “Company”), headquartered in Chestnut Ridge, NY, develops and deploys innovative and disruptive waste management technologies. The combined offerings of BioHiTech Global offer our customers a full suite of technology based disposal options capable of having a significant impact on waste generation, while providing a true zero landfill environment. With options for both on and off site biological treatment of waste, BioHiTech Global is a leader in zero waste solutions for businesses and municipalities. For more information, please visit www.biohitechglobal.com.

FOR MORE INFORMATION

Please visit: www.microcapconf.com

Or, contact Tony Yu at tony@microcapconf.com

IR Contact Information

Lisa Giovannielli
Director, Corporate Communications
845-262-1081
www.biohitechglobal.com

SOURCE: BioHiTech Global

ReleaseID: 457574

LOS ANGELES, CA / ACCESSWIRE / March 17, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Regulus Therapeutics Inc. (“Regulus” or the “Company”) (NASDAQ: RGLS). Investors, who purchased or otherwise acquired Regulus shares between January 21, 2016 and June 27, 2016, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 3, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

Regulus revealed that it was contacted by the U.S. Food and Drug Administration (“FDA”), stating that its new drug against the chronic hepatitis C virus infection will be placed on clinical hold due to another incidence of jaundice.

On January 27, 2017, Regulus disclosed that the FDA would not remove the clinical hold on RG-101 until the agency confirms the last safety and efficacy information from continued clinical and pre-clinical studies.

When this information was revealed to the investing public, shares of Regulus fell sharply, causing investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 457567

Many Shoppers who have Purchased the Durable and Top-Quality Runners Belt on the Oskiie Amazon Page have Posted a Review Describing How Well it Holds an Insulin Pump

LOS ANGELES, CA / ACCESSWIRE / March 17, 2017 / When the founders of Oskiie set out to create a high quality and durable fitness belt that men and women could use while working out, they probably had no idea that the belt would end up being highly useful for another important purpose.

But as the founders have learned – thanks in part to the positive reviews left by customers who have purchased the runners belt on the company’s Amazon page – the workout belt is also a highly effective insulin pump belt.

To learn more about the running belt from Oskiie and its many features that also make it a great and safe way to hold an expensive insulin pump, please check out https://www.amazon.com/Running-Belt-Exercise-Securely-Bouncing/dp/B01MTOF8Q2 at any time.

As a company spokesperson for Oskiie noted, it didn’t take long for people who have diabetes and rely on an insulin pump to keep their blood sugar at a normal level to realize that the comfortable and secure exercise belt was a perfect solution.

Not only is the fitness belt comfortable, it fits securely and snugly around the hips, and it is also bounce-free. This means that people who carry an expensive and vital insulin pump can rest assured that their needed equipment will stay put and will not fall out onto the ground while walking.

“The running belt also makes a great money belt or fanny pack to stash your iPhone or your keys, money, ID, hydration packs and gels,” the spokesperson said.

As a shopper named Sainath noted in a 5-star review on Amazon, the exercise belt from Oskiie fits perfectly and is a “nice snug belt” for an insulin pump.

“I use it with a tandem t:flex insulin pump, and it does not ride up or down and does not slide when I’m being active,” Sainath wrote in the review.

About Oskiie:

Oskiie is a new company that was established in 2015 and is located in Tampa, Florida. The company develops outdoor and sporting items that are fun, functional, and modernistic for all members of the family. Oskiie is committed to continuing to develop products that provide basic solutions in life. All Oskiie items including the running belt can be found and bought on Amazon. For more information, please visit https://www.amazon.com/Running-Belt-Exercise-Securely-Bouncing/dp/B01MTOF8Q2.

Contact:

Nichole Clark
admin@rocketfactor.com
(949) 555-2861

SOURCE: Oskiie

ReleaseID: 457571

The Film Sheds Light on the Long-Term Impacts of PTSD and Traumatic Brain Injury (TBI) on Veterans and Their Spouses

LOS ANGELES, CA / ACCESSWIRE / March 17, 2017 / Denise Weller, a choreographer and producer, recently announced the launch of her new film, “Blood Stripe, A Spouse’s Story.” The project tells the story of a veteran suffering from PTSD battles and his wife, who struggles to find her way back to the husband that she married.

To learn more about “Blood Stripe, A Spouse’s Story,” please visit https://goo.gl/HVNeF9

A combination of veteran spouse interviews and theatrical presentation, “Blood Stripe: A Spouse’s Story” seeks to deepen its audience’s understanding of the military and the veterans who cope with transitioning back to their families. By focusing on the spouse and family of an Iraq veteran, the Blood Stripe team highlights the need for education, resources, and support for anyone who comes back from war and those associated with them. “Blood Stripe: A Spouse’s Story” was inspired by the team’s own experiences with PTSD and TBI.

“The U.S. military spends enormous amounts of time and money preparing soldiers for war but very little of these resources preparing them to return to civilian life; and their spouses and families receive no preparation for what lies ahead,” stated a representative of the project.

“If we can educate the spouse to regarding the unique role they play in the recovery and reintegration of their Veteran into their family and the community, they have a chance to find a ‘new normal.'”

At this time, the Blood Stripe team has taken their project to Kickstarter, where they seek the necessary funds to complete the film’s production. The funds raised will cover costs such as location fees, equipment, and production staff fees. In exchange for the public’s support, the Blood Stripe team is offering a wide variety of perks, including art prints, DVDs, and tickets to the film’s premiere.

Individuals interested in learning more about “Blood Stripe, A Spouse’s Story” can visit the project’s Kickstarter page for additional information.

About “Blood Stripe, A Spouse’s Story”:

“Blood Stripe, A Spouse’s Story” is based on the actual experiences of a combat veteran who not only lost dozens of comrades, but also suffered a traumatic brain injury (TBI) from three IED explosions. The film takes a unique approach to storytelling and an intimate look at what life is like for this and other veterans who serve. Based on choreographer Denise Gula-Weller’s 2015 work of the same name, a socially relevant multi-media theatrical work, this film documentary brings to light the challenges faced by spouses and families who live daily with the consequences of war. For more information, please visit https://goo.gl/HVNeF9

Contact:

Cathy Gibbs
admin@rocketfactor.com
(949) 555-2861

SOURCE: Blood Stripe, A Spouse’s Story

ReleaseID: 457565

The Program Provides Students Ages 10 to 18 with the Opportunity to Refine Their Musical Abilities

LOS ANGELES, CA / ACCESSWIRE / March 17, 2017 / Mt. Blanca Summer Music Conservatory, a summer camp for students interested in bettering their musical talents, recently announced the launch of its Scholarship Program. The weeklong program is dedicated to providing young instrumental musicians with a quality education and the opportunity to perform live.

To learn more about Mt. Blanca Summer Music Conservatory Scholarship Program, please visit https://goo.gl/9dq7w6

When a student participates in the scholarship program, they are offered the chance to study and practice music by taking private lessons with faculty and collaborating with their peers through workshops, classes, and ensembles. They can perform solo, chamber, and orchestral pieces throughout the week, as well as participate in the honors recital and play alongside famous musicians. While curriculum typically includes music history theory, rhythm, and improvisation workshops, students also get the chance to request specific topics and tailor their education.

The cost for one student to attend MBSMC’s scholarship program is $700, which includes tuition, room, board, and a portion of the faculty’s pay. The program is made possible through Christmas concerts that provide basic operating funds, as well as generous patrons of the arts.

At this time, the MBSMC team is taking the scholarship program to Kickstarter, where it seeks the necessary funds to bring the summer camp to more students. MBSMC is offering a wide variety of perks to it’s campaign supporters, including tote bags, cutting boards, and DVDs of the students’ final recital. Sponsors also receive personal thank-you notes from the student that they helped.

“About 80 percent of past students needed a scholarship to attend MBSMC – 20 percent full-scholarship and 60 percent half-scholarship,” stated a representative of the program. “However, in order to expand our offerings to more students, we need additional support.”

Individuals interested in learning more about Mt. Blanca Summer Music Conservatory Scholarship Program can visit the project’s Kickstarter page for additional information.

About Mt. Blanca Summer Music Conservatory Scholarship Program:

MBSMC has a mission to serve students, ages 10 to 18, interested in refining their music skills. The program strives to serve students, especially in rural areas of Southern Colorado and Northern New Mexico. MBSMC’s staff is comprised of professional musicians who offer their time and talent, and the program encourages young talent of all levels to apply. For more information, please visit https://goo.gl/9dq7w6

Contact:

Roderick Perry
admin@rocketfactor.com
(949) 555-2861

SOURCE: Mt. Blanca Summer Music Conservatory Scholarship Program

ReleaseID: 457569

NEW YORK, NY / ACCESSWIRE / March 17, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against The Toronto-Dominion Bank (“TD” or the “Company”) (NYSE: TD) and certain of its officers, and is on behalf of a class consisting of all persons or entities who purchased TD securities between December 3, 2015 through March 9, 2017, both dates inclusive (the “Class Period”). Investors are encouraged to learn more about this case by visiting the firm’s site: http://www.bgandg.com/td.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed that: (1) TD’s wealth asset growth and increased fee-based revenue was spurred by a performance management system that steered to its employees breaking the law at their customer’s expense in order to meet sales targets; (2) TD illegitimately increased customer’s lines of credit and overdraft protection amounts without their knowledge; (3) TD illegitimately upgraded customers to higher-fee accounts without informing them; (4) TD lied to customers as to the risk of its products; and (5) consequently, defendants’ statements about TD’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On March 10, 2017, CBC News reported about the pressures put on TD Bank branch employees to sign up customers for products they don’t need. The report said that current and former TD employees described a pressure cooker environment that has “zero focus on ethics.” Following this news, TD stock dropped during intraday trading on March 10, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/td, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. You have until May 11, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 457514